.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
QuintilesIMS
Chinese Patent Office
Chubb
Baxter
US Department of Justice
AstraZeneca
Medtronic
Moodys
Dow

Generated: July 21, 2017

DrugPatentWatch Database Preview

NITRO-BID Drug Profile

« Back to Dashboard

What is the patent landscape for Nitro-bid, and what generic Nitro-bid alternatives are available?

Nitro-bid is a drug marketed by Sanofi Aventis Us and is included in two NDAs.

The generic ingredient in NITRO-BID is nitroglycerin. There are thirty-six drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the nitroglycerin profile page.

Summary for Tradename: NITRO-BID

Patents:0
Applicants:1
NDAs:2
Bulk Api Vendors: see list16
Clinical Trials: see list2,478
Patent Applications: see list2,292
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NITRO-BID at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us
NITRO-BID
nitroglycerin
INJECTABLE;INJECTION018621-001Jan 5, 1982DISCNNoNo► Subscribe► Subscribe
Sanofi Aventis Us
NITRO-BID
nitroglycerin
INJECTABLE;INJECTION071159-001Feb 28, 1990DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
QuintilesIMS
Farmers Insurance
Citi
Covington
Johnson and Johnson
Mallinckrodt
Moodys
Julphar
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot